Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - IMS Health Holdings, Inc.a51087503ex99_1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

April 24, 2015
Date of Report (Date of earliest event reported)


IMS Health Holdings, Inc.
(Exact name of registrant as specified in its charter)

Delaware   001-36381   27-1335689

(State or other

jurisdiction

(Commission File

Number)

(I.R.S. Employer
of incorporation) Identification No.)

 83 Wooster Heights Road
Danbury, CT 06810
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (203) 448-4600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 2.02           Results of Operations and Financial Condition.

On April 24, 2015, IMS Health Holdings, Inc. (the “Company”) issued a press release regarding financial results for the first quarter ended March 31, 2015. A copy of this press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

Item 9.01           Financial Statements and Exhibits.

(d) Exhibits

Exhibit
No.
  Description
 
99.1 Press Release dated April 24, 2015 issued by IMS Health Holdings, Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

IMS Health Holdings, Inc.

 

 

 

By: /s/ Ronald E. Bruehlman

Name:

Ronald E. Bruehlman

Title:

Senior Vice President &

Chief Financial Officer

Date: April 24, 2015


EXHIBIT INDEX

 

Exhibit No.

Description

99.1

Press Release dated April 24, 2015 issued by IMS Health Holdings, Inc.